Original Research
Published on 21 Apr 2023
Induction of unique macrophage subset by simultaneous stimulation with LPS and IL-4
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1111729
- 10,154 views
- 15 citations
Type at least 3 characters
2,748 articles
Articles
Original Research
Published on 21 Apr 2023
A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1105617
- 4,397 views
- 4 citations
Editorial
Published on 21 Apr 2023
Editorial: Next generation MSC therapy manufacturing, potency and mechanism of action analysis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1192636
- 3,560 views
- 6 citations
Original Research
Published on 21 Apr 2023
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1136029
- 2,440 views
- 3 citations
Original Research
Published on 21 Apr 2023
A novel multi-component protein vaccine ECP001 containing a protein polypeptide antigen nPstS1 riching in T-cell epitopes showed good immunogenicity and protection in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1138818
- 2,723 views
- 4 citations
Original Research
Published on 19 Apr 2023
Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a prospective, single-arm study
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1169666
- 2,444 views
- 5 citations
Review
Published on 19 Apr 2023
Immune interference in effectiveness of influenza and COVID-19 vaccination
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1167214
- 15,438 views
- 12 citations
Original Research
Published on 18 Apr 2023
Preparation of graphene oxide–stabilized Pickering emulsion adjuvant for Pgp3 recombinant vaccine and enhanced immunoprotection against Chlamydia Trachomatis infection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1148253
- 2,740 views
- 5 citations
Original Research
Published on 18 Apr 2023
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1155552
- 3,736 views
- 6 citations
Original Research
Published on 18 Apr 2023
Hemagglutinin expressed by yeast reshapes immune microenvironment and gut microbiota to trigger diverse anti-infection response in infected birds
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1125190
- 2,204 views
- 3 citations
Original Research
Published on 17 Apr 2023
The long-term antibody response after SARS-CoV-2 prime-boost vaccination in healthy individuals. The positive influence of extended between-dose intervals and heterologous schedule
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1141794
- 1,266 views
Review
Published on 17 Apr 2023
Reprogramming viral immune evasion for a rational design of next-generation vaccines for RNA viruses
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1172000
- 2,822 views
- 4 citations
Review
Published on 14 Apr 2023
Oral vaccination as a potential strategy to manage chronic wasting disease in wild cervid populations
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1156451
- 7,204 views
- 1 citation
Original Research
Published on 14 Apr 2023
Immunization with a novel mRNA vaccine, TGGT1_216200 mRNA-LNP, prolongs survival time in BALB/c mice against acute toxoplasmosis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1161507
- 4,163 views
- 5 citations
Brief Research Report
Published on 14 Apr 2023
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1182556
- 2,573 views
- 7 citations
Original Research
Published on 11 Apr 2023
Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1139620
- 3,325 views
- 6 citations